Ongoing Registry of Treatment of Venous Thromboembolism
NCT ID: NCT03881345
Last Updated: 2025-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
5000 participants
OBSERVATIONAL
2019-04-01
2036-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ongoing Registry of Treatment of Chronic Venous Diseases
NCT03035747
Mechanical Thrombectomy and Catheter Directed Thrombolysis Utilization in Patients With Deep Vein Thrombosis
NCT06468150
Registry for Chronic Venous Disease Incidence and Natural Course
NCT04487314
Inferior Vena Cava Filters: Analysis of a Database
NCT04330170
Complications of Gonadal Veins Embolization
NCT05085938
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There is planned to conduct prospective randomized, cohort and observational studies on the site of register
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Anticoagulants
anticoagulation according to the main diagnosis
Open surgery
removal of blood clots with open surgery
Thrombolysis
removal of blood clots with thrombolysis
Venous stenting
elimination of vein obstruction by stenting
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia
OTHER
Medalp Private Surgery Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Evgeny Ilyukhin
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pirogov Russian National Research Medical University
Moscow, Moscow, Russia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yury Stoyko, MD, PhD
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
Russian Registry of Treatment of Venous Thromboembolism (RRT VTE)
Russian Phlebological Association (RPA)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.